Track topics on Twitter Track topics that are important to you
Pharmion is a global specialty pharmaceutical company that is dedicated to the hematology and oncology communities. With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on acquiring, developing, and commercializing innovative products.
We work in partnership with a network of scientific and clinical advisors to identify and develop these products for global markets. To expand each product's potential, we have established our own commercial organizations in the United States, Europe, and Australia and have created distribution partnerships in 30 additional countries. With this international network we can reach physicians and their patients in more than 40 countries.
Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients' quality of life.
2525 28th St., Suite 200
United States of America
Phone: +1 720 564 9100
Fax: +1 720 564 9191
DelveInsight's, Thalomide Pharmion API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wi...
DelveInsight Drug Report, Thalomide Pharmion Drug Insights, 2017 highlights the Thalomide Pharmion marketed details, pipeline status and the Global API Manufacturers along with the location. The Delve...
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of b...
Vidaza™(azacitidine for injectable suspension)
The purpose of this study is to evaluate Thalidomide for treatment of disseminated MALT Lymphoma or at relapse following helicobacter pylori (HP) - eradication or chemotherapy or radiation...
The purpose of this research study is to find out what effects (good and bad) Vidaza has on patients with prostate cancer. This investigational drug is not approved by the Food and Drug A...
Pharmion is a global specialty pharmaceutical company that is dedicated to the hematology and oncology communities. With proven development and regulatory professionals and an experienced global comme...
Formed in 1999, Aberdare Ventures is aÂ San Francisco-based venture capital firm investing in visionary entrepreneurs and technologies that are transforming healthcare with new ...
MethylGene is a publicly-traded biopharmaceutical company listed on the Toronto Stock Exchange under the symbol MYG. We focus in the areas of cancer, infectious disease and other diseases such as diab...
We have published hundreds of Pharmion news stories on BioPortfolio along with dozens of Pharmion Clinical Trials and PubMed Articles about Pharmion for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmion Companies in our database. You can also find out about relevant Pharmion Drugs and Medications on this site too.
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...